Catalyst
Slingshot members are tracking this event:
Novartis (NVS) to submit biosimilar Pegfilgrastim for bone marrow stimulation to EU in second half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NVS | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 27, 2017
Occurred Source:
https://www.novartis.com/news/media-releases/sandoz-proposed-biosimilar-pegfilgrastim-accepted-ema-regulatory-review
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
European Medicines Agency, Bone Marrow Stimulation, Biosimilar, Pegfilgrastim
